Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

400

HTML

2778

Figures (1-4)

267

Tables (1-4)

233

Sum=3678

Mar 15, 2004 (publication date) through Jan 31, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Mar 15, 2004; 10(6): 813-818
Published online Mar 15, 2004. doi: 10.3748/wjg.v10.i6.813

Table 4 Expression of VEGF and MVD by immunohistochemi-cal staining (n=10)

¹SNK-q test: The difference between LP and control groups was not statistically significant.

Citation: Wu HP, Feng GS, Liang HM, Zheng CS, Li X. Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats. World J Gastroenterol 2004; 10(6): 813-818
URL: https://www.wjgnet.com/1007-9327/full/v10/i6/813.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i6.813